These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 523359)

  • 1. The influence of carbohydrases on the growth of fungal pathogens in vitro and in vivo.
    Pope AM; Davies DA
    Postgrad Med J; 1979 Sep; 55(647):674-6. PubMed ID: 523359
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mycolase, a new kind of systemic antimycotic.
    Davies DA; Pope AM
    Nature; 1978 May; 273(5659):235-6. PubMed ID: 643083
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of mycolase and amphotericin B on Candida albicans and Candida pseudotropicalis in vitro and in vivo.
    Chalkley LJ; Trinci AP; Pope AM
    Sabouraudia; 1985 Jun; 23(3):147-64. PubMed ID: 3895468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the fungal cell wall: current therapies and implications for development of alternative antifungal agents.
    Hasim S; Coleman JJ
    Future Med Chem; 2019 Apr; 11(8):869-883. PubMed ID: 30994368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro antifungal spectrum of itraconazole and treatment of systemic mycoses with old and new antimycotic agents.
    Van Cutsem J
    Chemotherapy; 1992; 38 Suppl 1():3-11. PubMed ID: 1319313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antifungal therapy: from amphotericin B to present.
    Dismukes WE
    Trans Am Clin Climatol Assoc; 1993; 104():166-77; discussion 177-9. PubMed ID: 1343440
    [No Abstract]   [Full Text] [Related]  

  • 7. Caspofungin: a major breakthrough in treatment of systemic fungal infections.
    Agarwal MB; Rathi SA; Ratho N; Subramanian R
    J Assoc Physicians India; 2006 Dec; 54():943-8. PubMed ID: 17334012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies in the treatment of systemic fungal infections.
    Medoff G; Kobayashi GS
    N Engl J Med; 1980 Jan; 302(3):145-55. PubMed ID: 6985703
    [No Abstract]   [Full Text] [Related]  

  • 9. Compounds active against cell walls of medically important fungi.
    Hector RF
    Clin Microbiol Rev; 1993 Jan; 6(1):1-21. PubMed ID: 8457977
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antifungal agents in the treatment of systemic infections: Relevance of mechanism of action, activity profile and resistances].
    Cuenca-Estrella M
    Rev Esp Quimioter; 2010 Dec; 23(4):169-76. PubMed ID: 21191554
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amphotericin B still in the headlines.
    Romani L
    Pathog Glob Health; 2012 May; 106(2):80-1. PubMed ID: 22943542
    [No Abstract]   [Full Text] [Related]  

  • 12. [Epidemiology and therapy of mycotic infections in immunocompromised host with special regard to the role of lipid formulations of amphotericin B].
    Viscoli C; Castagnola E
    Recenti Prog Med; 1999 Oct; 90(10):545-57. PubMed ID: 10592741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overview: antifungal combination therapy.
    Sugar AM
    Curr Opin Investig Drugs; 2001 Oct; 2(10):1364-5. PubMed ID: 11890347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of antimycotic activity of lyticase.
    Sachivkina NP; Kravtsov EG; Vasilyeva EA; Anokhina IV; Dalin MV
    Bull Exp Biol Med; 2009 Aug; 148(2):214-6. PubMed ID: 20027332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Caspofungin in the replacement of amphotericin B in the treatment of fungal diseases].
    Yang W; He B
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):53. PubMed ID: 15808079
    [No Abstract]   [Full Text] [Related]  

  • 16. New approaches to antifungal chemotherapy.
    Viviani MA; de Marie S; Graybill JR; Yamaguchi H; Anaissie E; Caillot D
    Med Mycol; 1998; 36 Suppl 1():194-206. PubMed ID: 9988508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Our pursuit for effective antifungal agents targeting fungal cell wall components: where are we?
    Ibe C; Oladele RO; Alamir O
    Int J Antimicrob Agents; 2022 Jan; 59(1):106477. PubMed ID: 34798234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic fungal infections in patients with hematologic malignancies: indications and limitations of the antifungal armamentarium.
    Böhme A; Karthaus M
    Chemotherapy; 1999; 45(5):315-24. PubMed ID: 10473919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Wide-range antifungal antagonism of Paenibacillus ehimensis IB-X-b and its dependence on chitinase and beta-1,3-glucanase production.
    Aktuganov G; Melentjev A; Galimzianova N; Khalikova E; Korpela T; Susi P
    Can J Microbiol; 2008 Jul; 54(7):577-87. PubMed ID: 18641704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Candida in denture plaque (2). Removal of Candida adhering to denture acrylic resin using yeast-lytic enzyme].
    Tamamoto M
    Hiroshima Daigaku Shigaku Zasshi; 1984 Dec; 16(2):250-9. PubMed ID: 6442924
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.